{"product_id":"elisa-kit-for-hemojuvelin-hjv-abcc24326","title":"ELISA Kit for Hemojuvelin (HJV)","description":"\u003ch4\u003eFormat\u003c\/h4\u003e\u003cp\u003e48T, \u003ci\u003e96T\u003c\/i\u003e, 96T×5, 96T×10, 96T×100\u003c\/p\u003e\u003ch4\u003eDetection range\u003c\/h4\u003e\u003cp\u003e12.35-1,000ng\/mL\u003c\/p\u003e\u003ch4\u003eApplication\u003c\/h4\u003e\u003cp\u003eEnzyme-linked immunosorbent assay for Antigen Detection.\u003c\/p\u003e\u003ch4\u003eOrganism species\u003c\/h4\u003e\u003cp\u003eHomo sapiens (Human)\u003c\/p\u003e\u003ch4\u003eSensitivity\u003c\/h4\u003e\u003cp\u003eThe minimum detectable dose of this kit is typically less than 4.93ng\/mL\u003c\/p\u003e\u003ch4\u003eSample type\u003c\/h4\u003e\u003cp\u003eSerum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids\u003c\/p\u003e\u003ch4\u003eAssay length\u003c\/h4\u003e\u003cp\u003e2h\u003c\/p\u003e\u003ch4\u003eMethod\u003c\/h4\u003e\u003cp\u003eCompetitive Inhibition\u003c\/p\u003e\u003ch4\u003eTest principle\u003c\/h4\u003e\u003cp\u003eThis assay employs the competitive inhibition enzyme immunoassay technique. A monoclonal antibody specific to Hemojuvelin (HJV) has been pre-coated onto a microplate. A competitive inhibition reaction is launched between biotin labeled Hemojuvelin (HJV) and unlabeled Hemojuvelin (HJV) (Standards or samples) with the pre-coated antibody specific to Hemojuvelin (HJV). After incubation the unbound conjugate is washed off. Next, avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. The amount of bound HRP conjugate is reverse proportional to the concentration of Hemojuvelin (HJV) in the sample. After addition of the substrate solution, the intensity of color developed is reverse proportional to the concentration of Hemojuvelin (HJV) in the sample.\u003c\/p\u003e\u003ch4\u003eAlternative Names\u003c\/h4\u003e\u003cp\u003eHFE2; HFE2A; HJV; JH; RGMC; hemochromatosis type 2(Juvenile); Haemojuvelin; RGM domain family member C\u003c\/p\u003e\u003ch4\u003eItem Name\u003c\/h4\u003e\u003cp\u003eHemojuvelin\u003c\/p\u003e\u003ch4\u003eResearch Area\u003c\/h4\u003e\u003cp\u003eMetabolic pathway;Infection immunity;Hematology;Nutrition metabolism;Hormone metabolism;\u003c\/p\u003e\u003ch4\u003eReference\u003c\/h4\u003e\u003cp\u003e\u003ca href=\"http:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ejh.12786\/full\"\u003eSoluble hemojuvelin in transfused and untransfused thalassaemic subjects\u003c\/a\u003e;\u003ca href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29699579\"\u003eUrinary biomarkers predict advanced acute kidney injury after cardiovascular surgery\u003c\/a\u003e;\u003ca href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29386545\"\u003eHemojuvelin Predicts Acute Kidney Injury and Poor Outcomes Following Cardiac Surgery\u003c\/a\u003e;\u003ca href=\"https:\/\/journals.sagepub.com\/doi\/abs\/10.1177\/0271678X19861448\"\u003eThe functional role of hemojuvelin in acute ischemic stroke\u003c\/a\u003e;\u003ca href=\"https:\/\/iris.unime.it\/retrieve\/handle\/11570\/3127002\/205108\/Tesi%20Dottorato%20Elisa%20Ferro.pdf\"\u003eOxidative damage and iron dyshomeostasis in thalassemic patients\u003c\/a\u003e;\u003c\/p\u003e","brand":"ABCbiolab","offers":[{"title":"96T \/ The minimum detectable dose of this kit is typically less than 4.93ng\/mL \/ Homo sapiens (Human)","offer_id":42481652957418,"sku":"ABCC24326","price":680.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0590\/5652\/1400\/products\/74120318_padded_logo_759dea8b-7771-4090-b227-2314a089df81.png?v=1644864949","url":"https:\/\/danabiosci.com\/products\/elisa-kit-for-hemojuvelin-hjv-abcc24326","provider":"Dana Bioscience","version":"1.0","type":"link"}